Patents
Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
04/2012
04/04/2012EP1677820B1 Colorectal cancer antigen
04/04/2012EP1660513B9 A ca6 antigen-specific cytotoxic conjugate and methods of using the same
04/04/2012EP1638994B1 Novel surface protein (hbsag) variant of hepatitis b virus
04/04/2012EP1397158B1 USE OF IgM ANTIBODIES AGAINST dsDNA IN SYSTEMIC LUPUS ERYTHEMATOSUS WITH NEPHRITIS
04/04/2012EP0783893B1 Inhibition of abnormal growth of synovial cells using il-6 antagonist as active ingredient
04/04/2012CN1602199B Gram positive bacteria preparations for the treatment of diseases comprising an immune dysregulation
04/04/2012CN1404399B Novel non-antigenic mucosal adjuvant formulation for modulating the effects of substances, including vaccine antigens in contact with mucosal body surface
04/04/2012CN102405237A 利用EphA3抗体治疗白血病和慢性骨髓增生性疾病 Antibody therapy using EphA3 leukemia and chronic myeloproliferative disorders
04/04/2012CN102405236A 改进的抗-tnfr1多肽,抗体可变结构域和拮抗剂 Improved anti -tnfr1 polypeptide, antibody variable domains and antagonists
04/04/2012CN102405235A Specific binding proteins and uses thereof
04/04/2012CN102405234A 用于天疱疮的含有抗Fas配体抗体的药物 For containing an anti-Fas ligand antibody drug pemphigus
04/04/2012CN102405058A 用于免疫接种水禽物种的重组禽疱疹病毒载体和疫苗 Recombinant avian herpes virus vectors and vaccines for the immunization of waterfowl species
04/04/2012CN102405057A Treatment of cancer with immunostimulatory HIV tat derivative polypeptides
04/04/2012CN102399807A 猪传染性胃肠炎s/n蛋白融合基因及重组乳酸乳球菌和应用 Transmissible Gastroenteritis s / n protein fusion gene and recombinant Lactococcus lactis and applications
04/04/2012CN102399806A 猪流行性腹泻S<sub>1</sub>蛋白融合基因及重组巨大芽孢杆菌和应用 Porcine epidemic diarrhea S <sub> 1 </ sub> fusion gene and recombinant protein of Bacillus megaterium and applications
04/04/2012CN102399805A 猪传染性胃肠炎病毒抗原融合基因及重组巨大芽孢杆菌菌株和应用 Porcine transmissible gastroenteritis virus antigen fusion gene and recombinant strains of Bacillus megaterium and applications
04/04/2012CN102399785A 一种免疫核酸(iRNA)的制备方法及其用途 An immune nucleic acid (iRNA) of the preparation method and use thereof
04/04/2012CN102399757A Immunogenic compositions and uses thereof
04/04/2012CN102399756A Chicken Marek's disease virus (MDV) miRNA (micro Ribonucleic Acid) deletion vaccine strain and application thereof
04/04/2012CN102399754A H9N2 avian influenza virus vaccine strain and application of H9N2 avian influenza virus vaccine strain in immune protection
04/04/2012CN102399751A Anti-mycobacterium tuberculosis monoclonal antibody, epitope recognized by anti-mycobacterium tuberculosis monoclonal antibody, and use thereof
04/04/2012CN102399749A Stable replication and expression cell line of Chinese patient C gene type multiple drug resistant HBV (Hepatitis B Virus)
04/04/2012CN102399724A 一种副猪嗜血杆菌lc株及其应用 A by-pig strains of Haemophilus lc Its Applications
04/04/2012CN102399289A 一种人源抗人IgE的抗体Fab片段、编码基因及用途 A humanized anti-human IgE antibody Fab fragments encoding gene and uses
04/04/2012CN102399266A 一种人源性电压门控钾通道1.5免疫原性肽段及其用途 A human-derived voltage-gated potassium channel 1.5 immunogenic peptides and their uses
04/04/2012CN102399265A Htnv-np 特异性的ctl 表位肽及其应用 Htnv-np specific ctl epitope peptide and its application
04/04/2012CN102399263A 鲤春病毒血症抗原表位 Spring viremia of carp epitope
04/04/2012CN102397560A Preparation method for avian pasteurella genome vaccine
04/04/2012CN102397559A Broad spectrum type influenza vaccine and preparation method thereof
04/04/2012CN102397557A Modification method for gold nanorods and gold nanorods-functional molecule composite
04/04/2012CN102397556A 鸭病毒性肝炎活疫苗用耐热保护剂及其制备方法和应用 Duck hepatitis vaccine with heat-resistant protective agent and its preparation method and application
04/04/2012CN102397544A 一种单克隆抗体用于治疗非小细胞肺癌的用途 Uses a monoclonal antibody for the treatment of non-small cell lung cancer
04/04/2012CN102397543A 一种单克隆抗体用于治疗胃癌的用途 A monoclonal antibody for use in the treatment of gastric cancer
04/04/2012CN102397542A 抗血管内皮生长因子受体-1的抗体 Anti-vascular endothelial growth factor receptor-1 antibodies
04/04/2012CN102397541A Preparation method for microencapsulated oral live vaccine of gosling plague
04/04/2012CN102397540A Recombinant phage vaccine for avian influenza A and construction method for recombinant phage vaccine
04/04/2012CN102397539A 鸭黄病毒病灭活疫苗及其制备方法 Duck flavivirus disease vaccine and its preparation method
04/04/2012CN102397538A 亚甲蓝光化学病毒灭活方法制备的病毒疫苗的应用 Application of methylene blue photochemical viral inactivation process for the preparation of viral vaccines
04/04/2012CN102397537A 迟钝爱德华菌外膜蛋白0245在制备疫苗中的应用 Edward 0245 retarded bacterial outer membrane protein for the preparation of a vaccine
04/04/2012CN101437537B 癌症疫苗 Cancer Vaccine
04/04/2012CN101076346B Lactic acid bacteria and its application in preventing diarrhea
04/03/2012USRE43298 Peptides as NS3-serine protease inhibitors of hepatitis C virus
04/03/2012US8148507 Nucleic acid encoding TNFx protein
04/03/2012US8148499 Vaccine
04/03/2012US8148497 Binding molecules capable of neutralizing rabies virus and uses thereof
04/03/2012US8148496 Multivalent antibody constructs
04/03/2012US8148493 Method for inhibiting “melanoma inhibitory activity” MIA
04/03/2012US8148340 Immunomodulatory oligonucleotides
04/03/2012US8148331 Method for the preparation of growth hormone and antagonist thereof having lower levels of isoform impurities thereof
04/03/2012US8148327 Aldosterone induced elastin production
04/03/2012US8148136 Diagnostics and vaccines for mycobacterial infections of animals and humans
04/03/2012US8148109 Interferon-like proteins and uses thereof
04/03/2012US8148080 Gene and protein relating to hepatocellular carcinoma and methods of use thereof
04/03/2012US8147850 Immunogenic constructs
04/03/2012US8147849 Protective antigens for group B Streptococcus hypervirulent strains
04/03/2012US8147848 Method for treating premature ejaculation with a botulinum neurotoxin
04/03/2012US8147847 Shigella protein antigens and methods
04/03/2012US8147846 Method for the treatment of airway diseases
04/03/2012US8147845 Reovirus clearance of ras-mediated neoplastic cells from mixed cellular compositions
04/03/2012US8147843 CD95L or trail fusion proteins
04/03/2012US8147842 Mutant luciferase
04/03/2012US8147841 Clostridium toxin, and process for the preparation of immunogenic composition
04/03/2012US8147840 Human immunodeficiency virus (HIV) immunization strategies employing conformationally-stabilized, surface-occluded peptides comprising a gp41 2F5 epitope in association with lipid
04/03/2012US8147839 Fusion proteins of HIV regulatory/accessory proteins
04/03/2012US8147837 Use of mycobacterial mannosylated lipoglycans peptide mimotopes for treating inflammation
04/03/2012US8147836 Compositions and methods for treating osteolytic disorders comprising MMP-14 binding proteins
04/03/2012US8147835 Molecularly engineered binding domain-immunoglobulin fusion proteins, including single chain Fv-immunoglobulin fusion protein useful for treating malignant conditions and B-cell disorders, such as disease caused by autoantibody production; chronic lymphocytic leukemia
04/03/2012US8147834 Anti-TGF-beta receptor II antibodies
04/03/2012US8147833 Prevention and treatment of synucleinopathic and amyloidogenic disease
04/03/2012US8147832 Diagnosis, therapy od autoimmune disease
04/03/2012US8147831 Anti-CD19 antibodies
04/03/2012US8147830 Antibody fragment-polymer conjugates and uses of same
04/03/2012US8147829 Anti-IGR-1R antibodies and uses thereof
04/03/2012US8147828 Methods and compositions for modulation of blood-neural barrier
04/03/2012US8147827 Tumor treatment
04/03/2012US8147820 Attenuated vaccine against fish pathogen Francisella sp
04/03/2012US8147819 Peptides for active anti-cytokine immunization
04/03/2012US8147769 Stent and delivery system with reduced chemical degradation
04/03/2012CA2586153C Mutant porcine reproductive and respiratory syndrome virus
04/03/2012CA2501690C Amended recombinant cells (arcs) for the production and delivery of antiviral agents, adjuvants and vaccine accelerants
04/03/2012CA2454618C Methods for treating or preventing sclerotic disorders using cd2-binding agents
04/03/2012CA2435466C Use of il-18 inhibitors for the treatment and/or prevention of heart disease
04/03/2012CA2433194C Comparative ligand mapping from mhc positive cells
04/03/2012CA2379220C Structural protein of adeno-associated virus with modified antigenicity, its production and its use
04/03/2012CA2347411C Virus-like particles for the induction of autoantibodies
04/03/2012CA2198461C Polynucleic acids isolated from a porcine reproductive and respiratory syndrome virus (prrsv), proteins encoded by the polynucleic acids, vaccines based on the proteins and/or polynucleic acids, a method of protecting a pig from a prrsv and a method of detecting a prrsv
04/01/2012CA2716236A1 Compositions for the treatment of hcv and hbv
03/2012
03/29/2012WO2012040562A2 Novel hiv-1 broadly neutralizing antibodies
03/29/2012WO2012040518A2 Carrier immunoglobulins and uses thereof
03/29/2012WO2012040474A2 Recombinant viral vectors and methods for inducing an immune response to yellow fever virus
03/29/2012WO2012040218A1 Recombinant flaviviral constructs and uses thereof
03/29/2012WO2012040164A2 Tlr5 ligands, therapeutic methods, and compositions related thereto
03/29/2012WO2012039607A1 Methods to produce bunyavirus replicon particles
03/29/2012WO2012038922A1 Immunomodulatory methods and systems for treatment and/or prevention of atherosclerosis and related proteins, peptides and compositions
03/29/2012WO2012038832A2 Generation of replicating chimeric measles virus - retrovirus particles
03/29/2012WO2012038825A2 Methods of increasing radiosensitivity using inhibitors of trefoil factor 1 (tff1)
03/29/2012WO2012038801A1 A spray dried powder formulation for vaccines entrapping alum and the antigen in biodegradable polymer particles
03/29/2012WO2012038573A1 Anti-ephrin-b2 antibody and use thereof
03/29/2012WO2012038540A2 Peptides
03/29/2012WO2012038504A2 Breast cancer therapeutics